STSP-0902

N/A

Report date: 2025/04/28 22:35:30

Base Information

Drug NameSTSP-0902
Drug Alias NameSTSP-0902STSP0902
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionNerve growth factor receptor Trk-A agonists
TargetsNerve growth factor receptor Trk-A
Therapy Area/IndicationsNeurotrophic KeratitisOligospermiaAsthenozoospermia +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesStaidson(Beijing) Biopharmaceuticals Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesStaidson(Beijing) Biopharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsNeurotrophic KeratitisOligospermiaAsthenozoospermia +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A